Dr. Deepak L. Bhatt and Dr. C. Michael Gibson Discuss: Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-year Follow-up of the SYMPLICITY HTN-3 Trial September 18, 2022 Disclosure: TBA
Dr. Ajay Kirtane Presents: Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Primary Results of the Randomized, Sham-Controlled RADIANCE II Pivotal Trial September 18, 2022 Disclosure: TBA
Dr. Sanjit Jolly and Dr. C. Michael Gibson Discuss: Ultrasound Guidance for Vascular Access for Cardiac Procedures: A Randomized Trial (UNIVERSAL) September 18, 2022 Disclosure: TBA
Dr. Catalin Toma and Dr. C. Michael Gibson Discuss: Outcomes for the Full US Cohort of the FLASH FlowTriever Mechanical Thrombectomy Registry in Pulmonary Embolism September 18, 2022 Disclosure:TBA
Dr. Shao-Ling Chen Presents: Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomised Trial September 18, 2022 Disclosure: TBA
Dr. Ajay Kirtane and Dr. C. Michael Gibson Discuss: TCT 2022 Daily Wrap-Up – September 17 2022 September 17, 2022 Disclosure: TBA
Dr. Jason Rogers and Dr. Ralph Stephan von Bardeleben and Dr. C. Michael Gibson Discuss: Contemporary Clinical and Echocardiographic Outcomes of 1000+ Patients Treated With MitraClip™ G4: Results From the EXPAND G4 Post Approval Study September 17, 2022 Disclosures: TBA
Dr. Dhanunjaya Lakkireddy and Dr. C. Michael Gibson Discuss: 3-Year Outcomes from the Amplatzer™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE) September 17, 2022 Disclosures: TBA
Dr. Aloke Finn and Dr. C. Michael Gibson Discuss: Pathology of Self-Expanding Transcatheter Aortic Valve Failure and Hypo-Attenuated Leaflet Thickening (HALT) September 17, 2022 Disclosures: TBA
Dr. Scott Lim and Dr. Konstantinos Koulogiannis and Dr. C. Michael Gibson Discuss: CLASP II D Trial: A Randomized Comparison of Transcatheter Edge-to-Edge Repair Devices for Degenerative Mitral Regurgitation – Clinical Outcomes and Echo Findings September 17, 2022 Disclosures: TBA
